UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

LBA-2 Primary analysis of MOUNTAINEER: A phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC

Annals of oncology, 2022-06, Vol.33, p.S375-S376

2022

Volltextzugriff (PDF)

Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer

The New England journal of medicine, 2023-01, Vol.388 (1), p.33-43

2023

Volltextzugriff (PDF)

Using the Systemic Inflammation Index (SII) as a Mid-Treatment Marker for Overall Survival among Patients Undergoing Chemo-Radiation Therapy for Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC): Secondary Analysis of PROCLAIM Trial

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.S103-S104

2020

Volltextzugriff (PDF)

510P Feasibility of non-operative management in patients with localized mismatch repair deficient (dMMR) gastrointestinal (GI) cancer receiving immunotherapy (IO)

Annals of oncology, 2024-06, Vol.35, p.S203-S203

2024

Volltextzugriff (PDF)

69P Circulating tumor DNA (ctDNA) dynamics in response to hepatic artery infusion pump therapy

Annals of oncology, 2024-06, Vol.35, p.S34-S34

2024

Volltextzugriff (PDF)

99P Circulating tumor DNA is prognostic for disease-free survival in patients with metastatic colorectal cancer undergoing definitive therapy

Annals of oncology, 2024-06, Vol.35, p.S47-S47

2024

Volltextzugriff (PDF)

SO-19 The outcome of resected stage II colon cancer patients with deficient mismatch repair T4 tumors: A National Cancer Database analysis

Annals of oncology, 2023-06, Vol.34, p.S170-S170

2023

Volltextzugriff (PDF)

P-219 Non-operative management of localized mismatch repair deficient colon cancer: A real-world perspective

Annals of oncology, 2023-06, Vol.34, p.S93-S93

2023

Volltextzugriff (PDF)

408P Retrospective analysis of concurrent chemoradiation with carboplatin/paclitaxel vs FOLFOX in esophageal adenocarcinoma

Annals of oncology, 2024-06, Vol.35, p.S166-S166

2024

Volltextzugriff (PDF)

Anti-GITR agonist TRX518 in combination with gemcitabine in advanced solid cancers: Preliminary safety and efficacy from a multi-center phase Ib trial

Annals of oncology, 2018-12, Vol.29, p.x29-x29

2018

Volltextzugriff (PDF)

OA01.03 Prognostic Role of NLR in Stage III NSCLC Undergoing Chemoradiation: Secondary Analysis of Proclaim Trial

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.S1125-S1125

2019

Volltextzugriff (PDF)

103P Temporospatial heterogeneity in metastatic colorectal cancer (mCRC)

Annals of oncology, 2020-12, Vol.31, p.S1458-S1458

2020

Volltextzugriff (PDF)

80PAnti-GITR agonist TRX518 in combination with gemcitabine in advanced solid cancers: Preliminary safety and efficacy from a multi-center phase Ib trial

Annals of oncology, 2018-12, Vol.29 (suppl_10)

2018

Volltextzugriff (PDF)

Treatment sequence and completion of perioperative chemotherapy in patients with pancreas cancer

HPB (Oxford, England), 2023, Vol.25, p.S97-S98

2023

Volltextzugriff (PDF)

Trends and disparities in chemotherapy utilization for metastatic hepatopancreatobiliary cancers

HPB (Oxford, England), 2023, Vol.25, p.S103-S104

2023

Volltextzugriff (PDF)

Guideline compliance for pancreatic adenocarcinoma at minority- vs. non-minority-serving hospitals

HPB (Oxford, England), 2023, Vol.25, p.S107-S108

2023

Volltextzugriff (PDF)

A Nationwide Analysis of Clinical Trial Participation for Common Hepato-pancreato-Biliary Malignancies Demonstrates Survival Advantages for Subsets of Trial Patients But Disparities and Infrequency of Enrollment

HPB (Oxford, England), 2022, Vol.24, p.S7-S7

2022

Volltextzugriff (PDF)

Combined Multiagent Chemotherapy and Radiotherapy Is Associated with Improved Survival Compared to Chemotherapy Alone in Patients with Non-Operatively Managed Stage II-III Pancreatic Adenocarcinoma

HPB (Oxford, England), 2022, Vol.24, p.S75-S76

2022

Volltextzugriff (PDF)

P-156 A phase Ib/II study of cetuximab and pembrolizumab in metastatic colorectal cancer

Annals of oncology, 2020-07, Vol.31, p.S140

2020

Volltextzugriff (PDF)

Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation

Contemporary clinical trials, 2008-03, Vol.29 (2), p.157-164

2008

Volltextzugriff (PDF)

Prognostic Role of NLR in Stage III NSCLC Undergoing Chemoradiation: Secondary Analysis of Proclaim Trial: OA01.03

Journal of thoracic oncology, 2019-11, Vol.14 (11 Suppl 1), p.S1125-S1125

2019

Volltextzugriff (PDF)

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2507-2507

2006

Volltextzugriff (PDF)

Pathobiology of T-cell and NK-cell lymphomas

Best practice & research. Clinical haematology, 2013-03, Vol.26 (1), p.75-87

2013

Volltextzugriff (PDF)

High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality

Biology of blood and marrow transplantation, 2005, Vol.11 (1), p.13-22

2005

Volltextzugriff (PDF)

Assessment and Treatment of Sleep in Mild Traumatic Brain Injury

Concussion, 2020, p.77-88

2020

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

LBA-2 Primary analysis of MOUNTAINEER: A phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC

Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer

Using the Systemic Inflammation Index (SII) as a Mid-Treatment Marker for Overall Survival among Patients Undergoing Chemo-Radiation Therapy for Stage-III Locally Advanced Non-Small Cell Lung Cancer (NSCLC): Secondary Analysis of PROCLAIM Trial

510P Feasibility of non-operative management in patients with localized mismatch repair deficient (dMMR) gastrointestinal (GI) cancer receiving immunotherapy (IO)

69P Circulating tumor DNA (ctDNA) dynamics in response to hepatic artery infusion pump therapy

99P Circulating tumor DNA is prognostic for disease-free survival in patients with metastatic colorectal cancer undergoing definitive therapy

SO-19 The outcome of resected stage II colon cancer patients with deficient mismatch repair T4 tumors: A National Cancer Database analysis

P-219 Non-operative management of localized mismatch repair deficient colon cancer: A real-world perspective

408P Retrospective analysis of concurrent chemoradiation with carboplatin/paclitaxel vs FOLFOX in esophageal adenocarcinoma

Anti-GITR agonist TRX518 in combination with gemcitabine in advanced solid cancers: Preliminary safety and efficacy from a multi-center phase Ib trial

OA01.03 Prognostic Role of NLR in Stage III NSCLC Undergoing Chemoradiation: Secondary Analysis of Proclaim Trial

103P Temporospatial heterogeneity in metastatic colorectal cancer (mCRC)

80PAnti-GITR agonist TRX518 in combination with gemcitabine in advanced solid cancers: Preliminary safety and efficacy from a multi-center phase Ib trial

Treatment sequence and completion of perioperative chemotherapy in patients with pancreas cancer

Trends and disparities in chemotherapy utilization for metastatic hepatopancreatobiliary cancers

Guideline compliance for pancreatic adenocarcinoma at minority- vs. non-minority-serving hospitals

A Nationwide Analysis of Clinical Trial Participation for Common Hepato-pancreato-Biliary Malignancies Demonstrates Survival Advantages for Subsets of Trial Patients But Disparities and Infrequency of Enrollment

Combined Multiagent Chemotherapy and Radiotherapy Is Associated with Improved Survival Compared to Chemotherapy Alone in Patients with Non-Operatively Managed Stage II-III Pancreatic Adenocarcinoma

P-156 A phase Ib/II study of cetuximab and pembrolizumab in metastatic colorectal cancer

Time-dependent effect of non-Hodgkin's lymphoma grade on disease-free survival of relapsed/refractory patients treated with high-dose chemotherapy plus autotransplantation

Prognostic Role of NLR in Stage III NSCLC Undergoing Chemoradiation: Secondary Analysis of Proclaim Trial: OA01.03

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody

Pathobiology of T-cell and NK-cell lymphomas

High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality

Assessment and Treatment of Sleep in Mild Traumatic Brain Injury

Suchergebnisse filtern